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ABSTRACT 
Indonesia’s biggest challenge in the next 10-15 years is non-communicable diseases (NCD) like cardiovascular and diabetes with 
its complication which are accounted for nearly 50 percent of deaths in the country. As of 2014, Indonesia’s diabetes population 
was the fifth largest in the world, International Diabetes Federation (IDF) predicted more than 14 million Indonesians will suffer 
diabetes in 2035. Dietary supplementation can reduce the risk of diabetes development and its cardiovascular complication. 
Indonesia as a country that is rich in natural sources has the opportunity to maximise the utilization and benefits of its natural 
products. Indonesian traditional herbs have been used to treat disease and nowadays they are being scientifically developed for 
therapies. These natural products are considered to have potentials in delaying the development of diabetes and its complications 
and to be able to cure the metabolic abnormalities using a variety of mechanism. Comprehensive literatures were used to review 
Indonesian traditional herbs used in the management of diabetes. An online database research from Elsevier, Science Direct, and 
PubMed was conducted to find literature on herbs growth in Indonesia that improves health outcomes in the development of 
diabetes and its cardiovascular complication. Indonesian traditional herbs such as Momordica chatarantia, Trigonella foenum-
graecum, Tinospora cordifolia, Zingiber officinale, Allium sativum have been proven to produce significant improvement of 
blood glucose, 2 hours post load glucose, A1C, LDL-C, blood pressure level as compared with control which have antidiabetic 
and cardioprotective activity with various mechanism of action. Indonesian scientifically proven traditional herbs have great 
potentials to be used as dietary supplementation to reduce the development of diabetes and its complication. It can be the 
investation to tackle the global challenge for reducing deaths caused by diabetes and its cardiovascular complication. 
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I.  INTRODUCTION 
Indonesia’s biggest challenge in the next 10-15 
years is non-communicable diseases (NCD) like 
cardiovascular and diabetes with its complication 
which are accounted for nearly 50 percent of deaths in 
the country. As of 2014, Indonesia’s diabetes 
population was the fifth largest in the world, 
International Diabetes Federation (IDF) predicted 
more than 14 million Indonesians will suffer diabetes 
in 2035 [1].  
Traditional herbs have an important role in primary 
health care of individuals in many developing 
countries e.g. Indonesia. In Indonesia, traditional 
herbs, known as “Jamu”, have been taken since long 
time ago and still popular on the Indonesian health 
care system. Traditional herbs are highly taken by 
people because it is cheaper than western medicines 
[2]. 
Dietary supplementation of traditional herbs can 
reduce the risk of diabetes development and its 
cardiovascular complication. Indonesia, as a country 
that is rich in natural sources, has the opportunity to 
maximise the utilization and benefits of its natural 
products. Indonesian traditional herbs have been used 
to treat disease and nowadays they are being 
scientifically developed for therapies. These natural 
products are considered to have potentials in delaying 
the development of diabetes and its complications and 
to be able to cure the metabolic abnormalities using a 
variety of mechanism [3]. 
II. DIABETES AND COMPLICATION 
Diabetes mellitus is a chronic illness and  define as 
“a metabolic disorder of multiple etiologies 
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characterized by chronic hyperglycemia with 
disturbances in carbohydrate, fat and protein 
metabolism resulting from defects in insulin secretion, 
insulin action, or both” [4]. In general, there are four 
classification of diabetes mellitus: type 1 diabetes 
mellitus, type 2 diabetes mellitus, gestational diabetes, 
and specific type of diabetes due to other cause [5]. 
Type 1 diabetes mellitus is insulin-dependent diabetes 
which occur due to destruction of β-cell of pancreas. 
Type 2 diabetes mellitus (non-insulin-dependent) is 
insulin resistance due to progressive loss of insulin 
secretion. Type 2 diabetes mellitus (T2DM) is the 
most common diabetes mellitus in people with 
diabetes and the result of physical inactivity and 
excess body weight. Gestational diabetes is diabetes 
that occur in pregnancy [5].  
Hyperglycemia is a pathological condition 
characterized by elevated blood glucose levels. It 
affects the mortality rate and caused the reduction of 
blood flow to the central nervous system area. It is a 
manifestation most commonly associated with such 
disease conditions as pre-diabetes and diabetes 
mellitus. The hyperglycemia seems to be involved in 
diabetic macrovascular complications [6,7,8]. It is a 
leading cause of nephropathy, retinopathy, and 
accelerated atherosclerosis [9]. 
In patients with T2DM, the frequency of 
atherosclerosis disease is increasing and causing the 
myocardial infarction, stroke, and gangrene in the 
lower part of the extremities. Increased risk of 
atherosclerosis in T2DM patients due to several 
reasons, those are the occurrence of hypertension and 
hyperlipidemia. The T2DM condition itself is the risk 
factor of atherosclerosis and has a synergistic activity 
with other risk factors that can increase the event of 
atherosclerosis. In T2DM, hypertension often occur on 
patient with obesity and those with insulin resistance 
[8].  
The central pathologic mechanism of cardiovascular 
disease is the process of atherosclerosis that causes 
narrowing the arterial wall in the body. Other risk 
factors are as follows: (a) changes in lipoprotein 
composition in T2DM make the particles in the blood 
vessels become more atherogenic; (b) procoagulant 
state in T2DM patients such as increased blood 
clotting factor and platelet aggregation; (c) 
proatherogenic changes in blood vessel walls; (d) 
proatherogenic changes in blood vessel walls due to 
the direct effect of blood hyperglycemia like the 
sedimentation of protein glycation only happened in 
microvascular complication; (e) pro-inflammation 
associated with the occurrence of insulin resistance 
[8,10]. 
III. INDONESIAN HERBS WITH 
ANTIDIABETIC AND RELATED BENEFICAL 
EFFECTS 
Nowadays, there has been increasing use of 
complementary and alternative medicine among global 
society. There were studies reported that almost 8% 
respondents with diabetes use alternative medicine. 
Another survey in specific diabetes populations two-
thirds and 49% of Hispanic population in South Texas 
used alternative medicine [11]. 
Part of plants and its derivates have been used in 
traditional medicine around the world including 
Indonesia [11]. As a tropical country with thousands of 
islands, Indonesia is gifted with a rich and unique 
biodiversity [3]. Indonesia is the world’s second 
largest biodiversity after Brazil and home for about 
90% of medicinal plants species found in Asia [11]. 
The area of Indonesian tropical forests is very wide 
and contain about 80% of the world’s medicinal 
plants. About 40 million Indonesian people have 
historically used the herbal medicines (known as 
“jamu”) for the treatment of diseases and dietary 
supplement [3]. This biodiversity rich have potential 
for future development of medicinal plants [12]. There 
are many herbal plants suggested for diabetes and its 
complication as follow : 
A. Momordica chatarantia 
Momordica chatarantia (MC) or usually called 
bitter melon is a flowering vine from the family of 
Cucurbitaceae. It is a tropical plant that is widely 
cultivated in Asia, India, East Africa, and South 
America for its intensely bitter fruits that are 
commonly used in cooking and as a natural remedy for 
treating diabetes. Bitter melon is one of the most 
beneficial plants for treating diabetes [13,14].  
Many parts of the plant had been used by the public 
for treating the T2DM, those parts were the leaves, the 
stem, and the green fruits or seed. It also often being 
extracted into a dry powder and consumed in the form 
of capsules, aqueous extract, powdered dried fruit or 
fresh juice. The main constituents of MC which are 
believed to have the antidiabetic effects and possessed 
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insulin-like chemical structure and properties are 
momocharin and momordicin. The momordicin 
belongs to alkaloid group which is responsible for the 
bitter taste of MC and momorcharin belongs to 
glycoproteins group that possessed hypoglycemic 
properties [13,14]. 
Many research reported the various mechanism of 
bitter melon as the antidiabetic agent for the patient 
with T2DM. It is believed to exert the hypoglycemic 
effect by involving the stimulation or inhibition of the 
key enzymes of metabolic pathways, it stimulates the 
key enzymes of hexose monophosphate pathway, 
increases the utilization of peripheral and skeletal 
muscle glucose, inhibits the intestinal glucose uptake 
and hexokinase activity, suppress the gluconeogenic 
enzymes, and maintain the normal function of islet β-
cells [15]. 
Rahman et al (2015) conducted a randomized 
control trial in human that proved the hypoglycemic 
and antiatherogenic effects of bitter melon compared to 
glibenclamide in T2DM patients [15]. The randomized 
controlled trial, double blind, and parallel group trial 
were involving 95 participants and divided into 3 
groups. The first group received bitter melon 2 g/day, 
the second group received bitter melon 4 g/day, and the 
third group received glibenclamide 2,5 mg/day for 10 
weeks. The result showed that there was significant 
reduction in A1C levels among patients in group 1, 2, 
and 3 from baseline to end-point after receiving the 
interventions. In group 1 and 2 which received bitter 
melon, the changes in 2 hours plasma glucose after oral 
glucose tolerance test (OGTT) were not statistically 
significant but the changes in fasting plasma glucose 
(FPG) were significant. Group 1 and 2 showed 
improvement in the changes of the blood lipid levels 
from baseline to end point but were not statistical 
significant except for triglyceride (TG), it also showed 
the favorable changes in body weight and systole blood 
pressure at the endpoint. The improvement on diabetes 
associated CV risk factor was better by bitter melon 
than glibenclamide, it might show that bitter melon less 
hypoglycemic but more antiatherogenic than 
glibenclamide [15]. 
A pilot study was conducted by Trakoon-osot et al 
in 2013 also showed that there was a significant 
reduction in A1C levels by consuming bitter melon for 
16 weeks [16]. The participants were divided into two 
groups and each group received 6 g/day of bitter melon 
dried-fruit pulp or placebo. After 8 weeks of the 
treatment the reduction of A1C from baseline in the 
group which was taking bitter melon was greater than 
that of the placebo group. Although the result of this 
study showed there was no significant reduction in 
FPG, but it proved that bitter melon was beneficial on 
the glycemic control and potential systemic 
complication of T2DM [16].  
B. Trigonella foenum-graecum 
Trigonella foenum-graecum L. seeds (TFG), family 
Fabaceae, known as fenugreek, halba or helba, kelabat 
is commonly used in cooking especially for curry [17]. 
TFG seeds or its extracts can be used for their nutritive 
and therapeutic values in many parts of the world, 
especially in China, Egypt, India and Middle Eastern 
countries [17]. The present study has found TFG seeds 
can be used for diet supplementation on blood glucose 
and lipid profile in T2DM patients. Active compounds 
of fenugreek included soluble fiber, saponins, 
trigonell, diosgenin, and 4-hydroxyisoleucine. Marker 
compound for hypoglycemic activities have mainly 
been attributed to dietary fiber and saponin, alkaloids, 
amino acids, galactomannan, nicotinicacid, vitamins 
and minerals [17]. Soluble fibers like galactomannan 
help in slowing down digestion affect blood sugar 
reduction and absorption of carbohydrates [19]. 
Saponins form large mixed micelles with bile salts and 
significantly reduce cholesterol by increasing fecal 
excretion of bile salts, thereby inhibiting cholesterol 
absorption [19]. 4-Hydroxy leucine found in these 
seeds stimulates insulin secretion in pancreas and 
lowers absorption of glucose [19]. 
Shakour et al (2003) reported that fenugreek seed 
dietary supplements may be beneficial to T2DM 
patients and its compliance to reduce blood glucose 
[18]. The subjects divided to 5 groups, 25 patients 
included control group receiving diets recommended 
by the diabetes institute with no other diet 
supplementation, group received boiled fenugreek 
seeds as diet supplementation, group received 
germinated fenugreek seeds as diet supplementation, 
group received fenugreek seeds in powder form for 
diet supplementation, and group received defated 
fenugreek seeds for diet supplementation. All 
fenugreek was given in a daily dose of 15 g. The 
results told that there was no significant change in 
blood glucose, fructosamine and lipid profile. But, 
there was a significant change in improved serum 
cholesterol, serum TG, Low Density Lipoprotein 
(LDL) and Very Low Density Lipoprotein (VLDL). 
And also there was a significant change that reduced 
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postprandial blood glucose level in all groups that 
received the fenugreek seed supplement [18].  
Kumar et al (2015) reported that fenugreek seeds 
can control T2DM in the form of soaked in hot water 
[19]. The subject divided into two equal groups 
included Group took 5 grams fenugreek seeds powder 
into 250 g yoghurt and other group used the same 
amounts into one quart hot water before lunch and 
dinner (10 grams per day) for two months. The results 
of 18 patients (11 consumed fenugreek in hot water 
and 7 in yoghurt) were studied. Only group that 
received fenugreek seeds was significantly reduced in 
Fasting Blood Glucose (FBG) (25%), TG (30%) and 
VLDL (30.6%) [19]. 
C. Zingiber officinale 
The rhizome of the plants Zingiber officinale 
(Zingiberaceae) commonly known as ginger (“Jahe” in 
Indonesia) is extensively used as spicy and medicine. 
In ancient medical use as “Jamu” in Indonesia, ginger 
has been used for gastrointestinal disorder. Ginger 
supplementation improves glucose homeostatis in 
T2DM by decreasing insulin resistance and improve 
glucose tolerance despite of the mechanism remains 
uncertain. Ginger’s major chemical compound include 
phenolic compound gingerol and shogaol take role of 
carbohydrate metabolism and hyperglycemia with α-
amilase and α-glucosidase inhibition [20]. In vivo 
study trial showed the ability of gingerol to decrease 
blood sugar and oxidative stress due to superoxide 
dismutase stimulation. Treatment with gingerol 
resulted in plasma insulin level [21]. 
There are some scientific evidences on the effects 
of ginger on the blood levels. A randomized clinical 
trial with double-blind, placebo controlled conducted 
by Shidfar et al [20] on 45 old patients with T2DM 
[23]. The subject received 3 g of powdered ginger 
daily in 3 months. The study’s results showed that 
after intervention the reduction of FBG (–19.41 ± 
18.83) and A1C (−0.77 ± 0.88) were significantly 
different (p< 0.001). In another randomized, double-
blind, placebo-controlled, clinical trial conducted by 
Khandouzi et al. (2015) [22]. 41 T2DM subjects 
recruited have given oral administration of ginger 
powder for 12 weeks at dose of 2 g per day caused 
significant (p=0.000) reduction in the levels of FBG (-
19.41 ± 18.83) [22]. 
Inflammation is play major role in pathogenesis of 
its secondary complications. A studies conducted by 
Shidfar et al., (2015) there is significantly reduction 
(p<0.001) of C-reactive protein (CRP) as inflammation 
marker (-2,78 ± 4,07) in 45 old patients with T2DM 
received 3 g of powdered ginger daily in 3 months 
[20]. These evidence supported by trials that 
conducted by Azimi et al., [23] the CRP decrease 
significantly (p<0.05) within group (5.65 ± 0.1 to 5.55 
± 0.1). 
D. Tinospora cordifolia 
Tinospora cordifolia (Willd.) Hook.f. & Thomson 
(TC) is a medicinal plant which has the potential for 
anti-diabetic and anti-dyslipidemic because of its high 
alkaloid and terpenes content. Its stem contains some 
medicinal substances berberine, palmatine, 
tembetarine, magnoflorine, tinosporin, tinocordifolin 
[24]. 
The alcoholic extract of stem has anti diabetic and 
antihyperlipidemic effect and it has been demonstrated 
in Wistar rats for its effect. The potential effect of TC 
extract is better to reduce diabetic-dyslipidemia and 
extrapancreatic and intrapancreatic activities are 
known to take part in the anti-diabetic effect. There is 
no available study on humans after knowing its great 
potential on the glycemic and lipemic profile in animal 
models. The stem of TC has great potential to control 
dyslipidemia and T2DM [24]. 
The study from this article recruited 100 patients 
T2DM from the Medicine and Diabetic OPD of King 
George Medical University who met the inclusion 
criteria (age of patients between 30-60 years and a 
known case type 2 diabetes mellitus with taking oral 
antidiabetic drugs). The exclusion criteria for the 
patients were type 2 diabetes patients with insulin, 
type 1 diabetes and gestational diabetic patients, 
patients above 60 years, patients with nephropathy, 
neuropathy, retinopathy, and any other chronic 
complication. 100 patients who met the inclusion 
criteria were randomly divided into two groups, group 
A and B. Patients in group A were treated as control 
(continued to take oral antidiabetic drugs) and patients 
in group B were given extract of TC in tablet form as 
add-on therapy alongside the oral antidiabetic drugs. A 
TC tablet contained 500 mg extract was given three 
times a day with meals for 6 months. Each patient 
body mass index (BMI), blood pressure, age, weight, 
weight was recorded for baseline characteristics [24]. 
The results of this study after 6 months: the 
baseline parameters were not statistically significant 
	
	
10	
	
The	5th	AASIC	2017	
(similar from the beginning of this study); the 
reduction of FBG levels was statistically significant in 
group A (p≤0,05) and highly significant in group B 
(p≤0,005); the reduction of post prandial blood glucose 
levels was statistically significant in group A and B 
(p≤0,05); the reduction A1C of group B was more 
statistically significant than group A [24]. 
59 patients who met the inclusion criteria (T2DM 
and dyslipidemia and were taking oral antidiabetic 
drugs and statins) were recruited. The exclusion 
criteria of this study were patients with secondary 
complication, gestational diabetes, and type 1 diabetes. 
The patients divided into 2 groups, intervention group 
(n=29) and control group (n=30). The intervention 
group accepted 250 mg of encapsulated mature stem of 
TC and took it before meals twice daily alongside the 
dyslipidemia and antidiabetic drugs, but the control 
group only took the oral dyslipidemia and antidiabetic 
drugs for 2 months. All parameters were checked 
before and after 2 months of study to evaluate the 
effect of the intervention. The results of this study after 
2 months: the reduction of CRP was statistically 
significant; the A1C was similar with the beginning of 
the study; average blood glucose (ABG) was 
decreased and reached nearly statistically significant 
[25]. 
 
E. Allium sativum 
Allium sativum (AS), known as garlic or “bawang 
putih” in Indonesian, had commonly used both as 
cooking flavor agent and medicine. AS contains a 
variety of sulfur-containing compounds, amino acids, 
vitamins, and minerals. Some of the sulfur-containing 
compounds were allicin, ajoene, S-allylcysteine, S-
methylcysteine, diallyl disulfide and sulfoxides [26]. 
As a dietary supplement, AS is available in many 
preparation, such as dehydrated garlic powder, garlic 
oil (steam-distilled), garlic essential oil 
(etherextracted), aged garlic extract (AGE), and garlic 
oil macerate, and each form contains a markedly 
different set of compounds that affect the chemical 
properties, including the active compound. Garlic 
powder are the most commonly reported and used in 
garlic preparation, that has active compound alliin 
derivates, allicin [27]. 
AS has shown potential effect on the anticoagulant 
activity, antioxidant, antihyperlipidemic, 
antihypertensive, antiatherogenic, and antiglycemic 
effect [4].  The effect of AS on antiglycemic and 
antihyperlipidemic were not apparent. The probable 
mechanism AS in antiglycemic effects is increased 
insulin secretion, insulin sensitivity, enhancement of 
beta cell in pancreas by activating regeneration of the 
cell, and also antioxidant effect of AS [28,29]. As 
antihyperlipidemic agent, AS inhibiting 
hydroxymethylglutaryl-CoA reductase (HMG-CoA 
reductase), by allicin [29]. 
Effect AS on the diabetic and hyperlipidemia has 
been reported in many previous clinical study. A 
control study (n=210) with garlic tablet contain 300, 
600, 900, 1200 and 1500 mg/ day for 24 week has 
shown significant reduction FBG and improvement in 
A1C [30]. This garlic tablet compared to placebo and 
metformin. The higher the dose of garlic, the higher 
the effect in FBG and A1C. Other study showed 
significant reduction in FBG, mean total cholesterol, 
LDL-C, TG, and improvement in High Density 
Lipoprotein cholesterol (HDL-C) after 24 weeks of 
treatment [29]. In this study, garlic combined with 
typical antidiabetic agent. The meta-analysis showed 
that the administration of garlic resulted in a 
significant reduction in FBG concentrations [28]. Few 
adverse effects had reported in clinical studies using 
AS consist of gastrointestinal discomfort and nausea, 
allergic contact dermatitis, rhinitis, bloating, headache, 
dizziness [29,30]. 
Overall, garlic showed significant effect on 
prevention diabetes mellitus and its complication as 
single treatment and with combination with 
antidiabetic agent, and may be a potential addition in 
the treatment of patients with T2DM and 
hyperlipidemia. 
IV. CONCLUSION 
Indonesian scientifically proven traditional herbs 
have potentials to be used as dietary supplementation to 
reduce the development of diabetes and its 
complication. Indonesian traditional herbs such as 
Momordica chatarantia called bitter melon; seeds of 
Trigonella foenum-graecum, rhizome of Zingiber 
officinale; stems of Tinospora cordifolia; roots of 
Allium sativum are represent the herbs which are most 
frequently used as herbal medicine. These plants have 
been studied intensively up to clinical trial stage for 
their activity in reducing diabetic development and its 
secondary complications. The mechanisms of action of 
these plants in reducing diabetic factors have been 
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studied in molecular level lately. Therefore, it can be 
the investment to tackle the global challenge for 
reducing deaths caused by diabetes and its 
cardiovascular complication. 
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